SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.

SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.

The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female vaginal transmission of HIV infection among women at high risk.This was a Phase 3, double-blind, randomized, placebo-controlled trial. Participants made up to 12 monthly follow-up visits...

Full description

Bibliographic Details
Main Authors: Paul J Feldblum, Adesina Adeiga, Rashidi Bakare, Silver Wevill, Anja Lendvay, Fatimah Obadaki, M Onikepe Olayemi, Lily Wang, Kavita Nanda, Wes Rountree
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2190795?pdf=render

Internet

http://europepmc.org/articles/PMC2190795?pdf=render

Similar Items